Physician profile
Haley Maser
NPI 1245806058
$1,622.27
in general payments reported to CMS, 2019-2025
11 companies · $801 in 2025
The $801 reported for 2025 was more than what 85% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $332 · 2024: $489 · 2025: $801.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,622.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $359.27 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astrazeneca Pharmaceuticals LP | $258.89 | 2024-2025 | Wainua, Fasenra |
| Bayer Healthcare Pharmaceuticals INC. | $222.34 | 2024-2025 | |
| Novo Nordisk INC | $203.42 | 2025 | Wegovy |
| Pulmonx Corporation | $125.56 | 2025 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Amgen INC. | $107.89 | 2025 | Tepezza |
| Gilead Sciences, INC. | $97.02 | 2024 | Veklury |
| Madrigal Pharmaceuticals | $87.61 | 2024 | Rezdiffra |
| Abbvie INC. | $72.88 | 2023 | |
| Boston Scientific Corporation | $71.99 | 2023 | Watchman, Watchman Flx |
| Ucb, INC. | $15.40 | 2025 | Bimzelx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Maser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.